Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
CTT Pharmaceutical Holdings, Inc.
- Market Cap
- Unavailable
- Price
- $0.057
- % Change (Daily % change from the live per-ticker quote feed.)
- -1.72%
- Volume
- 40.3K
About
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion. Its principal asset is a patented orally administered dissolvable strip. The company is based in Tampa, Florida.
Quick stats
Shares outstanding—
Computed float18.5M
Float / sharesUnknown
Key info
SectorHealthcare
IndustryMedical - Pharmaceuticals
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001035422
AI Summary
AI-generated1/6
minorbullishclinical trial
CTT Pharma Signs LOI for Clinical Trials and Testing of Nicotine Products
CTT Pharmaceutical Holdings signed a Letter of Intent with a US-based testing company to conduct clinical trials for its potential nicotine products.
This partnership aims to enable CTT Pharma to independently commercialize its patented thin-film technology in the United States.
The company stated it will notify shareholders as more information becomes available, indicating the deal is in early stages.
Red flags
- LOI is non-binding and preliminary
- No specific timeline or financial terms disclosed
- Counterparty testing company is unnamed